Florence Healthcare Acquires VersaTrial
September 25, 2023
Florence Healthcare, a Site Enablement Platform provider, acquired VersaTrial, a clinical trial site solutions provider, to enhance site enablement capabilities and streamline operations for research sites, sponsors and CROs. The deal will integrate VersaTrial’s features to reduce technology burden, speed feasibility responses, and improve communication across study personnel within Florence’s global network of connected sites.
- Buyers
- Florence Healthcare
- Targets
- VersaTrial
- Industry
- Cloud & SaaS
- Location
- Connecticut, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Advarra Acquires Forte
September 5, 2019
Software
Advarra, a leading provider of IRB and research compliance services, announced its intent to acquire Forte, a market-leading provider of clinical research technology including the OnCore CTMS. The deal (Forte sold by Primus Capital) expands Advarra's site-centric technology and eClinical capabilities to better serve academic medical centers, cancer centers, and health systems.
-
Signant Health Acquires VirTrial from Kinderhook Industries
January 6, 2021
Healthcare Services
Signant Health has acquired VirTrial, a Scottsdale-based provider of telemedicine and virtual site monitoring software for clinical trials, from private equity owner Kinderhook Industries. The acquisition expands Signant Health's digital clinical-trial capabilities by adding VirTrial's virtual-visit, secure video/chat, connected device and virtual site monitoring solutions to Signant's evidence-generation technology stack.
-
GHO Capital Acquires Velocity Clinical Research
July 15, 2021
Healthcare Services
Global Healthcare Opportunities (GHO) has acquired Durham-based Velocity Clinical Research from NaviMed Capital and other investors. GHO intends to support Velocity’s roll-up strategy of clinical trial sites, expand its integrated site model (including investment in technology and decentralized trial capabilities) and pursue further geographic expansion, including into Europe.
-
Velocity Clinical Research Acquires TrierHealth
February 22, 2022
Healthcare Services
Durham-based Velocity Clinical Research acquired digital clinical trials platform TrierHealth, bringing its founder Raghu Punnamraju into Velocity as Chief Technology Officer. The acquisition adds Hyderabad-based R&D talent and patient-engagement technology to accelerate Velocity’s move toward decentralized and hybrid clinical trials.
-
WCG Acquires VeraSci
July 26, 2021
Healthcare Services
WCG acquired VeraSci, a Durham-based provider of eClinical software and specialty scientific expertise for CNS-focused clinical trials, to deepen its CNS scientific capabilities and expand remote data capture and decentralized trial solutions. VeraSci will operate as WCG VeraSci and remain headquartered in North Carolina while retaining its leadership team.
-
Velocity Clinical Research Acquires eStudySite Inc
November 11, 2020
Healthcare Services
Velocity Clinical Research has acquired eStudySite Inc, adding two San Diego locations (La Mesa and Chula Vista) to its U.S. site portfolio and bringing the company's total to 14 sites. The deal is intended to improve recruitment of volunteers from minority communities and expand Velocity's infectious disease and vaccine trial capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.